Elicio Therapeutics announced it has set the date for its 2026 annual meeting of stockholders for November 12, 2026. Due to the meeting date changing by more than 30 days from the anniversary of the prior year's meeting, the company has established a new, earlier deadline for shareholder proposals and director nominations.
Key Details
- Annual Meeting Date: The meeting is scheduled to be held on November 12, 2026.
- New Shareholder Proposal Deadline: All stockholder proposals, including director nominations and items under Rule 14a-8, must be received by the company no later than September 24, 2026, to be considered timely.
- Reason for New Deadline: The deadline was adjusted because the 2026 annual meeting date has been delayed by more than 30 days from the anniversary of the company's last annual meeting.